A Study of Trifluridine/Tipiracil in Triple Negative Metastatic Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Metastatic Triple Negative Breast Cancer
Interventions: DRUG: Trifluridine/Tipiracil
Sponsor: AHS Cancer Control Alberta
Collaborators: Tom Baker Cancer Centre